Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / virus - Page 6

virus

CDC announced H5N1 bird flu virus in U.S. wild birds and poultry posed a low risk to the public
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Veterinary

CDC announced H5N1 bird flu virus in U.S. wild birds and poultry posed a low risk to the public

On Feb. 14, 2022, the U.S. Centers for Disease Control and Prevention (CDC) reported that the current risk…

Read More CDC announced H5N1 bird flu virus in U.S. wild birds and poultry posed a low risk to the publicContinue

Research scientists identified vulnerable site on multiple coronaviruses that could be targeted to prevent future pandemics.
Life Science History | Vaccine

Research scientists identified vulnerable site on multiple coronaviruses that could be targeted to prevent future pandemics.

On Feb. 10, 2022, Scripps Research announced that the COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the…

Read More Research scientists identified vulnerable site on multiple coronaviruses that could be targeted to prevent future pandemics.Continue

Data suggested sotrovimab retained neutralizing activity against Omicron subvariant BA.2
Life Science History

Data suggested sotrovimab retained neutralizing activity against Omicron subvariant BA.2

On Feb. 10, 2022, Vir Biotech announced that preclinical data suggested that sotrovimab, an investigational monoclonal antibody authorized…

Read More Data suggested sotrovimab retained neutralizing activity against Omicron subvariant BA.2Continue

NIH-funded study suggested COVID-19 increased risk of pregnancy complications
COVID-19 | Life Science History | NIH

NIH-funded study suggested COVID-19 increased risk of pregnancy complications

On Feb. 4, 2022, the NIH announced a study that showed pregnant women with COVID-19 appeared to be…

Read More NIH-funded study suggested COVID-19 increased risk of pregnancy complicationsContinue

Cocrystal Pharma selected two lead antiviral drug candidates for COVID-19 oral drug program
Biotechnology | COVID-19 | Therapeutics

Cocrystal Pharma selected two lead antiviral drug candidates for COVID-19 oral drug program

On Jan. 27, 2022, Cocrystal Pharma announced that it had selected two investigational novel antiviral drug candidates for…

Read More Cocrystal Pharma selected two lead antiviral drug candidates for COVID-19 oral drug programContinue

Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19
COVID-19 | Life Science History

Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19

On Jan. 27, 2022, NIAID announced that a clinical trial found that the combination of remdesivir plus a…

Read More Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19Continue

Report published in PNAS detailed spread and evolution of SARS-CoV-2 in white-tailed deer across the U.S.
Life Science History

Report published in PNAS detailed spread and evolution of SARS-CoV-2 in white-tailed deer across the U.S.

On Jan. 25. 2022, a report published in PNAS provided strong evidence of extensive SARS-CoV-2 infection of white-tailed…

Read More Report published in PNAS detailed spread and evolution of SARS-CoV-2 in white-tailed deer across the U.S.Continue

Mixed vaccine schedules offered strong booster responses after two doses of CoronaVac vaccine
Life Science History | Vaccine

Mixed vaccine schedules offered strong booster responses after two doses of CoronaVac vaccine

On Jan. 24, 2022, the University of Oxford announced that a third booster dose of either the ChAdOx1…

Read More Mixed vaccine schedules offered strong booster responses after two doses of CoronaVac vaccineContinue

Anixa Biosciences  and MolGenie announced early potency analysis of SARS-CoV-2 protease inhibitor
Biotechnology | COVID-19 | HIV | Infectious Disease

Anixa Biosciences and MolGenie announced early potency analysis of SARS-CoV-2 protease inhibitor

On Jan. 24, 2022, Anixa Biosciences announced that the company and its partner, MolGenie, had synthesized a compound…

Read More Anixa Biosciences and MolGenie announced early potency analysis of SARS-CoV-2 protease inhibitorContinue

‘Ultrapotent’ antibodies neutralized SARS-CoV-2 variants in NIAID study
Biotechnology | COVID-19 | NIH | Therapeutics

‘Ultrapotent’ antibodies neutralized SARS-CoV-2 variants in NIAID study

On Jan. 20, 2022, scientists from the National Institute of Allergy and Infectious Diseases (NIAID) announced that they…

Read More ‘Ultrapotent’ antibodies neutralized SARS-CoV-2 variants in NIAID studyContinue

Australia Therapeutic Goods Administration granted provisional registration for Novavax COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Australia Therapeutic Goods Administration granted provisional registration for Novavax COVID-19 vaccine

On Jan. 19, 2022, Novavaxa announced that Australia’s Therapeutic Goods Administration had granted approval for provisional registration of…

Read More Australia Therapeutic Goods Administration granted provisional registration for Novavax COVID-19 vaccineContinue

USDA confirmed highly pathogenic avian influenza in a wild bird in South Carolina
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Veterinary

USDA confirmed highly pathogenic avian influenza in a wild bird in South Carolina

On Jan. 14, 2022, the U.S. Department of Agriculture’s (USDA) National Veterinary Services Laboratories confirmed a highly pathogenic…

Read More USDA confirmed highly pathogenic avian influenza in a wild bird in South CarolinaContinue

U.S. FDA authorizd InteliSwabル COVID-19 rapid tests for at-home testing for delta variant detection
COVID-19 | Life Science History

U.S. FDA authorizd InteliSwabル COVID-19 rapid tests for at-home testing for delta variant detection

On Jan. 13, 2022, OraSure Technologies that its InteliSwabᆴ COVID-19 rapid tests detected the Omicron variant as effectively…

Read More U.S. FDA authorizd InteliSwabル COVID-19 rapid tests for at-home testing for delta variant detectionContinue

CDC study showed flu vaccination prevented severe flu Illness in U.S. children
Influenza | Life Science History | Vaccine

CDC study showed flu vaccination prevented severe flu Illness in U.S. children

On Jan. 13, 2022, the Centers for Disease Control and Prevention announced a study published in the journal…

Read More CDC study showed flu vaccination prevented severe flu Illness in U.S. childrenContinue

Pfizer and BioNTech signed global collaboration agreement to develop first mRNA-based shingles vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Pfizer and BioNTech signed global collaboration agreement to develop first mRNA-based shingles vaccine

On Jan. 5, 2022, Pfizer and BioNTech announced a new research, development and commercialization collaboration to develop a…

Read More Pfizer and BioNTech signed global collaboration agreement to develop first mRNA-based shingles vaccineContinue

Hologic added Aptima SARS-CoV-2 assay to its Global Access Initiative in resource-limited countries
HIV | Life Science History

Hologic added Aptima SARS-CoV-2 assay to its Global Access Initiative in resource-limited countries

On Jan 5, 2022, Hologic the addition of the Aptimaᆴ SARS-CoV-2 assay to its Global Access Initiative, a…

Read More Hologic added Aptima SARS-CoV-2 assay to its Global Access Initiative in resource-limited countriesContinue

Revelar Biotherapeutics and Twist Bioscience announced RBT-0813 neutralized SARS-CoV-2 Omicron and Delta variants
Life Science History

Revelar Biotherapeutics and Twist Bioscience announced RBT-0813 neutralized SARS-CoV-2 Omicron and Delta variants

On Jan 5, 2022, Revelar Biotherapeutics and Twist Bioscience announced that RBT-0813 binded to and neutralized the Omicron…

Read More Revelar Biotherapeutics and Twist Bioscience announced RBT-0813 neutralized SARS-CoV-2 Omicron and Delta variantsContinue

Development of WRAI’s pan-coronavirus vaccine showed promise
COVID-19 | Infectious Disease | Non-Profit Research | Vaccine

Development of WRAI’s pan-coronavirus vaccine showed promise

On Dec. 28, 2021, researchers at the Walter Reed Army Institute of Research in Silver Spring, Maryland announced…

Read More Development of WRAI’s pan-coronavirus vaccine showed promiseContinue

PacBio’s HiFiViral Surveillance Kit Performance not impacted by Omicron mutations
Biotechnology | COVID-19 | Disease | Genomics

PacBio’s HiFiViral Surveillance Kit Performance not impacted by Omicron mutations

On Dec. 28, 2021, Pacific Biosciences announced that its new HiFiViral SARS-CoV-2 solution had successfully sequenced and captured…

Read More PacBio’s HiFiViral Surveillance Kit Performance not impacted by Omicron mutationsContinue

Sorrento announced COVISTIX COVID-19 virus rapid antigen detection test detected the Omicron variant
Biotechnology | COVID-19 | Vaccine

Sorrento announced COVISTIX COVID-19 virus rapid antigen detection test detected the Omicron variant

On Dec. 27, 2021, Sorrento Therapeutics announced that initial testing of COVISTIX on recombinant N proteins demonstrated its…

Read More Sorrento announced COVISTIX COVID-19 virus rapid antigen detection test detected the Omicron variantContinue

Merck and Ridgeback’s molnupiravir received U.S. FDA EUA for treatment of high-risk adults with COVID-19
Biotechnology | COVID-19 | FDA | Medicine | Pharmaceutical | Therapeutics

Merck and Ridgeback’s molnupiravir received U.S. FDA EUA for treatment of high-risk adults with COVID-19

On Dec. 23, 2021, Merck and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) had…

Read More Merck and Ridgeback’s molnupiravir received U.S. FDA EUA for treatment of high-risk adults with COVID-19Continue

University of Oxford team published blueprint for making millions of doses of a new vaccine within 100-days
Life Science History | Vaccine

University of Oxford team published blueprint for making millions of doses of a new vaccine within 100-days

On Dec. 22, 2021, the University of Oxfordメs vaccine manufacturing research team published a pre-print paper demonstrating the…

Read More University of Oxford team published blueprint for making millions of doses of a new vaccine within 100-daysContinue

Pfizer received U.S. FDA Emergency Use Authorization for novel COVID-19 oral antiviral treatment
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Pfizer received U.S. FDA Emergency Use Authorization for novel COVID-19 oral antiviral treatment

On Dec. 22, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had authorized the emergency…

Read More Pfizer received U.S. FDA Emergency Use Authorization for novel COVID-19 oral antiviral treatmentContinue

USDA confirmed COVID-19 in a Canada lynx at a Pennsylvania zoo
Agriculture | COVID-19 | Life Science History | Veterinary

USDA confirmed COVID-19 in a Canada lynx at a Pennsylvania zoo

On Dec. 21, 2021, the United States Department of Agricultureメs National Veterinary Services Laboratories announced confirmation of SARS-CoV-2…

Read More USDA confirmed COVID-19 in a Canada lynx at a Pennsylvania zooContinue

Oxford team published blueprint for making millions of doses of a new vaccine within 100 days
Biotechnology | COVID-19 | Therapeutics | Vaccine

Oxford team published blueprint for making millions of doses of a new vaccine within 100 days

On Dec. 21, 2021, the University of Oxford’s vaccine manufacturing research team published a pre-print paper demonstrating the…

Read More Oxford team published blueprint for making millions of doses of a new vaccine within 100 daysContinue

Novavax and Serum Institute of India announced WHO Emergency Use listing for NVX-CoV2373 COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine | WHO

Novavax and Serum Institute of India announced WHO Emergency Use listing for NVX-CoV2373 COVID-19 vaccine

On Dec. 17, 2021, Novavax and SK bioscience announced that the World Health Organization (WHO) had granted Emergency…

Read More Novavax and Serum Institute of India announced WHO Emergency Use listing for NVX-CoV2373 COVID-19 vaccineContinue

NIH scientists urged pursuit of universal coronavirus vaccine
Life Science History | NIH | Vaccine

NIH scientists urged pursuit of universal coronavirus vaccine

On Dec. 16, 2021, NIH scientists announced that to counter future coronavirus outbreaks, the global scientific and medical…

Read More NIH scientists urged pursuit of universal coronavirus vaccineContinue

Moderna and Australia announced collaboration to bring mRNA manufacturing to Australia
Biotechnology | Infectious Disease | Vaccine

Moderna and Australia announced collaboration to bring mRNA manufacturing to Australia

On Dec. 13, 2021, Moderna announced an agreement with the Australian Government to build a state-of-the-art messenger RNA…

Read More Moderna and Australia announced collaboration to bring mRNA manufacturing to AustraliaContinue

CEPI partnered with Affinivax to develop a novel COVID-19 vaccine to target variants
COVID-19 | Life Science History | Vaccine

CEPI partnered with Affinivax to develop a novel COVID-19 vaccine to target variants

On Dec. 13, 2021, the Coalition for Epidemic Preparedness Innovations, and Affinivax announced a partnership to advance the…

Read More CEPI partnered with Affinivax to develop a novel COVID-19 vaccine to target variantsContinue

FDA authorized long-acting monoclonal antibodies for pre-exposure prevention of COVID-19 in certain individuals
COVID-19 | Life Science History

FDA authorized long-acting monoclonal antibodies for pre-exposure prevention of COVID-19 in certain individuals

On Dec. 8, 2021, the U.S. Food and Drug Administration issued an emergency use authorization for AstraZenecaメs Evusheld…

Read More FDA authorized long-acting monoclonal antibodies for pre-exposure prevention of COVID-19 in certain individualsContinue

Page navigation

Previous PagePrevious 1 … 4 5 6 7 8 … 39 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search